(PDF) P19-55 LB. Effective Control of a Pathogenic

P19-55 LB. Effective Control of a Pathogenic SIVmac239 Challenge by a Novel Heterologous Mucosal Prime and Intramuscular Boost Vaccine Strategy

Retrovirology - United Kingdom

doi 10.1186/1742-4690-6-s3-p419

Full Text

Abstract

Available in full text

Categories

Infectious Diseases

Date

October 1, 2009

Authors

Publisher

Springer Science and Business Media LLC

Related search

Accelerated Heterologous Adenovirus Prime-Boost SIV Vaccine in Neonatal Rhesus Monkeys

Journal of Virology

English

Immunogenicity of Heterologous Recombinant Adenovirus Prime-Boost Vaccine Regimens Is Enhanced by Circumventing Vector Cross-Reactivity

Journal of Virology

English

Significant Protection Against High-Dose Simian Immunodeficiency Virus Challenge Conferred by a New Prime-Boost Vaccine Regimen

Journal of Virology

English

Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma Cruzi

Frontiers in Immunology

English

Preferential Targeting of Conserved Gag Regions After Vaccination With a Heterologous DNA Prime Modified Vaccinia Ankara Boost HIV Vaccine Regime

Infectious Diseases

English

Optimized Mucosal MVA Prime/Soluble Gp120 Boost Vaccination Regimen Induces Similar Antibody Responses as an Intramuscular Regimen

Journal of Virology

English

Prime–boost Approaches to Tuberculosis Vaccine Development

Expert Review of Vaccines

Molecular Medicine

English

Prime-Boost Strategies for Malaria Vaccine Development

Journal of Experimental Biology

Molecular Biology

Aquatic Science

English

Granulocyte-Macrophage Colony-Stimulating Factor DNA Prime-Protein Boost Strategy to Enhance Efficacy of a Recombinant Pertussis DNA Vaccine

Acta Pharmacologica Sinica

English